バーチャル臨床試験の世界市場規模調査＆予測、試験デザイン別、適応症別、フェーズ別、地域別分析、2023年～2030年

世界のバーチャル臨床試験市場は、2022年に約82億8,000万米ドルと評価され、予測期間2023年から2030年にかけて5.7%以上の成長率で成長すると予測されています。

バーチャル臨床試験とは、デジタル技術と遠隔モニタリングを活用して参加者からデータを収集する、臨床研究の現代的なアプローチを指します。参加者が通常、物理的な治験施設を訪れる従来の臨床試験とは異なり、VCTはバーチャルまたはオンラインプラットフォームを活用し、臨床試験プロセスの様々な側面を促進します。バーチャル臨床試験市場は、心血管疾患の罹患率上昇やがん患者数の増加などの要因によって拡大しています。その結果、2023年～2030年の予測期間中、国際市場ではバーチャル臨床試験の需要が徐々に増加しています。

バーチャル臨床試験は、ヘルスケア専門家と遠隔で相談するための遠隔医療を取り入れることが多いです。これは、特に心血管疾患のある患者にとって有益であり、物理的な訪問を必要とせずに医療専門家との定期的なチェックインが可能になります。2020年の米国心臓協会によると、CVD関連死の41.2％は冠動脈性心疾患であり、次いで脳卒中17.3％、その他の心血管系疾患16.8％、高血圧12.9％、心不全9.2％、動脈疾患2.6％となっています。Virtual Clinical Trials市場を牽引するもう一つの重要な要因は、がん患者の増加です。がん治療では、患者の健康状態や治療反応を継続的にモニタリングする必要がある場合が多いです。デジタルツールやウェアラブルデバイスを使用したバーチャル臨床試験は、参加者のリアルタイムかつ継続的なモニタリングを可能にし、患者の状態や治療結果についてより包括的な理解を提供します。また、国際がん研究機関によると、2022年の世界のがんによる死亡者数は996万人と推定され、2030年には1,290万人に達すると予測されています。さらに、臨床研究数の増加とバーチャル臨床試験に関連する技術の進歩は、予測期間中に市場に有利な成長機会を創出すると予想されます。しかし、バーチャル臨床試験の高い市場開拓コストとバーチャル臨床試験の実施における厳格な規制が、2023年から2030年の予測期間を通じて市場全体の成長を阻害することになるでしょう。

バーチャル臨床試験の世界市場調査において考慮した主な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、ICON plcやIQVIA Holdings, Inc.など複数のプレイヤーの存在感が高まっていること、また同地域でバーチャル臨床試験に対する政府の取り組みが活発化していることから、2022年の市場を独占しました。政府は、バーチャル臨床試験をサポートするために必要な技術インフラの構築に投資することができます。これには、インターネット接続の改善、遠隔医療プラットフォームの利用促進、データセキュリティとプライバシーコンプライアンスの確保などが含まれます。この地域の圧倒的な実績は、バーチャル臨床試験の全体的な需要を促進すると予想されます。さらに、アジア太平洋地域は予測期間中に最も急速に成長すると予想されます。これは、同地域における心血管疾患の増加率や老人人口の増加といった要因によるものです。高齢者は、特に健康状態に既往症がある場合、旅行中の有害事象や合併症の影響を受けやすいです。バーチャル参加は、旅行に伴う潜在的な健康リスクへの曝露を最小限に抑え、参加者の全体的な安全と幸福に貢献します。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のバーチャル臨床試験市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 バーチャル臨床試験の世界市場力学

• バーチャル臨床試験市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 心血管疾患の増加
    • がん患者の増加
  • 市場の課題
    • バーチャル臨床試験の開発コストの高さ
    • バーチャル臨床試験の実施における厳しい規制
  • 市場機会
    • 臨床研究数の増加
    • バーチャル臨床試験に関連する技術の進歩

第4章 バーチャル臨床試験の世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 バーチャル臨床試験の世界市場：試験デザイン別

• 市場スナップショット
• バーチャル臨床試験の世界市場：試験デザイン別、実績 - ポテンシャル分析
• バーチャル臨床試験の世界市場：試験デザイン別推定・予測、2020年～2030年
• バーチャル臨床試験市場、サブセグメント分析
  • 介入試験
  • 観察試験
  • 拡張アクセス

第6章 バーチャル臨床試験の世界市場：適応症別

• 市場スナップショット
• バーチャル臨床試験の世界市場：適応症別、実績-潜在能力分析
• バーチャル臨床試験の世界市場、適応症別推計・予測、2020年～2030年
• バーチャル臨床試験市場、サブセグメント分析
  • 中枢神経系
  • 自己免疫/炎症
  • 心血管疾患
  • 代謝/内分泌
  • 感染症
  • その他

第7章 バーチャル臨床試験の世界市場：フェーズ別

• 市場スナップショット
• バーチャル臨床試験の世界市場：フェーズ別、実績-潜在能力分析
• バーチャル臨床試験の世界市場、フェーズ別推定・予測、2020年～2030年
• バーチャル臨床試験市場、サブセグメント分析
  • フェーズi
  • フェーズII
  • フェーズIII
  • フェーズIV

第8章 バーチャル臨床試験の世界市場：地域別分析

• 主要国
• 新興国
• バーチャル臨床試験市場、地域別市場スナップショット
• 北米
  • 米国
    • 試験デザイン別の推定・予測、2020年～2030年
    • 適応症の推定・予測、2020年～2030年
    • フェーズ別推定・予測、2020年～2030年
  • カナダ
• 欧州のバーチャル臨床試験市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋のバーチャル臨床試験市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカのバーチャル臨床試験市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Icon plc
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Parexel International Corporation
  • Covance Inc
  • PRA Health Sciences, Inc
  • LEO Innovation Lab A/S
  • Medidata Solutions, Inc
  • Oracle Corporation
  • Croprime Pty Ltd
  • Clinical Ink, Inc
  • Medable Inc

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Virtual Clinical Trials Market, report scope
• TABLE 2.Global Virtual Clinical Trials Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Virtual Clinical Trials Market estimates & forecasts by Study Design 2020-2030 (USD Billion)
• TABLE 4.Global Virtual Clinical Trials Market estimates & forecasts by Indication 2020-2030 (USD Billion)
• TABLE 5.Global Virtual Clinical Trials Market estimates & forecasts by Phase 2020-2030 (USD Billion)
• TABLE 6.Global Virtual Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Virtual Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Virtual Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Virtual Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Virtual Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Virtual Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Virtual Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Virtual Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Virtual Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Virtual Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Virtual Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Virtual Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Virtual Clinical Trials Market
• TABLE 71.List of primary sources, used in the study of global Virtual Clinical Trials Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Virtual Clinical Trials Market, research methodology
• FIG 2.Global Virtual Clinical Trials Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Virtual Clinical Trials Market, key trends 2022
• FIG 5.Global Virtual Clinical Trials Market, growth prospects 2023-2030
• FIG 6.Global Virtual Clinical Trials Market, porters 5 force model
• FIG 7.Global Virtual Clinical Trials Market, pest analysis
• FIG 8.Global Virtual Clinical Trials Market, value chain analysis
• FIG 9.Global Virtual Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Virtual Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Virtual Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Virtual Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Virtual Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Virtual Clinical Trials Market, regional snapshot 2020 & 2030
• FIG 15.North America Virtual Clinical Trials Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Virtual Clinical Trials Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Virtual Clinical Trials Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Virtual Clinical Trials Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Virtual Clinical Trials Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Virtual Clinical Trials Market is valued approximately at USD 8.28 billion in 2022 and is anticipated to grow with a growth rate of more than 5.7% over the forecast period 2023-2030. Virtual Clinical Trials refer to a modern approach in conducting clinical research that leverages digital technologies and remote monitoring to collect data from participants. Unlike traditional clinical trials, where participants typically visit physical study sites, VCTs utilize virtual or online platforms to facilitate various aspects of the trial process. The Virtual Clinical Trials market is expanding because of factors such as rising incidence of cardiovascular disease and growing number of cancer cases. As a result, the demand of Virtual Clinical Trials has progressively increased in the international market during the forecast period 2023-2030.

Virtual trials often incorporate telemedicine for remote consultations with healthcare professionals. This is especially valuable for individuals with cardiovascular conditions could benefit from regular check-ins with medical professionals without the need for physical visits. According to the American Heart Association in 2020, the United States, coronary heart disease was held accountable for the primary cause, responsible for 41.2% of CVD-related deaths, followed by stroke at 17.3%, other cardiovascular diseases at 16.8%, high blood pressure at 12.9%, heart failure at 9.2%, and diseases of the arteries at 2.6%. Another important factor drives the Virtual Clinical Trials market is increasing number of cancer cases. Cancer treatments often require ongoing monitoring of patients' health and treatment responses. Virtual clinical trials with the use of digital tools and wearable devices, enable real-time and continuous monitoring of participants, providing a more comprehensive understanding of their condition and treatment outcomes. In addition, as per International Agency for Research on Cancer, in 2022, global estimated number of deaths due to cancer accounts 9.96 million and projected to reached up to 12.9 million by 2030. Moreover, rising number of clinical research studies and technological advancements associated with virtual clinical trials is anticipated to create a lucrative growth opportunity for the market over the forecast period. However, high development cost of virtual clinical trials and stringent regulation in performing virtual clinical trials is going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Virtual Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing presence of several players such as ICON plc; IQVIA Holdings, Inc. and growing supportive government initiatives towards virtual clinical trials in the region. Governments can invest in building the necessary technological infrastructure to support virtual clinical trials. This includes improving internet connectivity, promoting the use of telemedicine platforms, and ensuring data security and privacy compliance. The region's dominant performance is anticipated to propel the overall demand of Virtual Clinical Trials. Furthermore, Asia Pacific is expected to grow fastest during the forecast period, owing to factors such as growing rate of cardiovascular diseases and rising number of geriatric populations in the region. Older individuals could be more susceptible to adverse events or complications during travel, especially if they have pre-existing health conditions. Virtual participation minimizes exposure to potential health risks associated with travel, contributing to the overall safety and well-being of participants.

Major market player included in this report are:

• Icon plc
• Parexel International Corporation
• Covance Inc
• PRA Health Sciences, Inc
• LEO Innovation Lab A/S
• Medidata Solutions, Inc
• Oracle Corporation
• Croprime Pty Ltd
• Clinical Ink, Inc
• Medable Inc

Recent Developments in the Market:

• In February 2024, Curavit Clinical Research, a virtual contract research organisation (VCRO) that specialises in decentralised clinical trials (DCTs) for digital therapeutics (DTx), has completed a decentralised trial for the Sana Device. Sana has submitted trial data to the US Food and Drug Administration (FDA) for consideration as a Breakthrough Device Designation for its wearable, virtual-reality-style mask that uses audiovisual stimulation to treat symptoms of post-traumatic stress disorder. The Sana Device is a wearable device designed to provide anxiety alleviation on demand. The trial was funded by a CDMRP grant administered by the Military Operational Medicine Research Programme. Its purpose was to gather evidence on the Device's capacity to provide additional alleviation to patients suffering from PTSD.

Global Virtual Clinical Trials Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Study Design, Indication, Phase, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Study Design

• Interventional
• Observational
• Expanded Access

By Indication

• CNS
• Autoimmune/Inflammation
• Cardiovascular Disease
• Metabolic/Endocrinology
• Infectious Disease
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Virtual Clinical Trials Market, by region, 2020-2030 (USD Billion)
  • 1.2.2.Virtual Clinical Trials Market, by Study Design, 2020-2030 (USD Billion)
  • 1.2.3.Virtual Clinical Trials Market, by Indication, 2020-2030 (USD Billion)
  • 1.2.4.Virtual Clinical Trials Market, by Phase, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Virtual Clinical Trials Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Virtual Clinical Trials Market Dynamics

• 3.1.Virtual Clinical Trials Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Rising incidences of cardiovascular disease
    • 3.1.1.2.Growing number of cancer cases
  • 3.1.2.Market Challenges
    • 3.1.2.1.High development cost of virtual clinical trials
    • 3.1.2.2.Stringent regulation in performing virtual clinical trials
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Rising number of clinical research studies
    • 3.1.3.2.Technological advancements associated with virtual clinical trials

Chapter 4.Global Virtual Clinical Trials Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economic
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Virtual Clinical Trials Market, by Study Design

• 5.1.Market Snapshot
• 5.2.Global Virtual Clinical Trials Market by Study Design, Performance - Potential Analysis
• 5.3.Global Virtual Clinical Trials Market Estimates & Forecasts by Study Design 2020-2030 (USD Billion)
• 5.4.Virtual Clinical Trials Market, Sub Segment Analysis
  • 5.4.1.Interventional
  • 5.4.2.Observational
  • 5.4.3.Expanded Access

Chapter 6.Global Virtual Clinical Trials Market, by Indication

• 6.1.Market Snapshot
• 6.2.Global Virtual Clinical Trials Market by Indication, Performance - Potential Analysis
• 6.3.Global Virtual Clinical Trials Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
• 6.4.Virtual Clinical Trials Market, Sub Segment Analysis
  • 6.4.1.CNS
  • 6.4.2.Autoimmune/Inflammation
  • 6.4.3.Cardiovascular Disease
  • 6.4.4.Metabolic/Endocrinology
  • 6.4.5.Infectious Disease
  • 6.4.6.Others

Chapter 7.Global Virtual Clinical Trials Market, by Phase

• 7.1.Market Snapshot
• 7.2.Global Virtual Clinical Trials Market by Phase, Performance - Potential Analysis
• 7.3.Global Virtual Clinical Trials Market Estimates & Forecasts by Phase 2020-2030 (USD Billion)
• 7.4.Virtual Clinical Trials Market, Sub Segment Analysis
  • 7.4.1.Phase I
  • 7.4.2.Phase II
  • 7.4.3.Phase III
  • 7.4.4.Phase IV

Chapter 8.Global Virtual Clinical Trials Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Virtual Clinical Trials Market, Regional Market Snapshot
• 8.4.North America Virtual Clinical Trials Market
  • 8.4.1.U.S. Virtual Clinical Trials Market
    • 8.4.1.1.Study Design breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Indication breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.Phase breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Virtual Clinical Trials Market
• 8.5.Europe Virtual Clinical Trials Market Snapshot
  • 8.5.1.U.K. Virtual Clinical Trials Market
  • 8.5.2.Germany Virtual Clinical Trials Market
  • 8.5.3.France Virtual Clinical Trials Market
  • 8.5.4.Spain Virtual Clinical Trials Market
  • 8.5.5.Italy Virtual Clinical Trials Market
  • 8.5.6.Rest of Europe Virtual Clinical Trials Market
• 8.6.Asia-Pacific Virtual Clinical Trials Market Snapshot
  • 8.6.1.China Virtual Clinical Trials Market
  • 8.6.2.India Virtual Clinical Trials Market
  • 8.6.3.Japan Virtual Clinical Trials Market
  • 8.6.4.Australia Virtual Clinical Trials Market
  • 8.6.5.South Korea Virtual Clinical Trials Market
  • 8.6.6.Rest of Asia Pacific Virtual Clinical Trials Market
• 8.7.Latin America Virtual Clinical Trials Market Snapshot
  • 8.7.1.Brazil Virtual Clinical Trials Market
  • 8.7.2.Mexico Virtual Clinical Trials Market
• 8.8.Middle East & Africa Virtual Clinical Trials Market
  • 8.8.1.Saudi Arabia Virtual Clinical Trials Market
  • 8.8.2.South Africa Virtual Clinical Trials Market
  • 8.8.3.Rest of Middle East & Africa Virtual Clinical Trials Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1. Icon plc
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Parexel International Corporation
  • 9.3.3.Covance Inc
  • 9.3.4.PRA Health Sciences, Inc
  • 9.3.5.LEO Innovation Lab A/S
  • 9.3.6.Medidata Solutions, Inc
  • 9.3.7.Oracle Corporation
  • 9.3.8.Croprime Pty Ltd
  • 9.3.9.Clinical Ink, Inc
  • 9.3.10.Medable Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption